Science Explorer Back to mapMap
Discussion
Topic · Surgery

Infectious Diseases and Tuberculosis

Infectious Diseases and Tuberculosis is a research topic within Surgery. Science Explorer counts 35k research works in it since 1950. 10.0% of them reached the world's top 10% most cited for their field and year.

This cluster of papers focuses on the diagnosis and treatment of spinal infections, particularly spinal epidural abscess, tuberculous meningitis, and vertebral osteomyelitis. It also explores the immune reconstitution inflammatory syndrome in patients with HIV infection undergoing antiretroviral therapy. The papers cover various aspects such as clinical presentation, management, outcomes, risk factors, and meta-analyses related to these spinal infections.

  • Spinal Epidural Abscess
  • Tuberculous Meningitis
  • Vertebral Osteomyelitis
  • Immune Reconstitution Inflammatory Syndrome
  • HIV Infection
  • Antiretroviral Therapy
  • Diagnostic Imaging
  • Surgical Management
  • Meta-analysis
  • Clinical Practice Guidelines
Research works
35k
fractional, since 1950
In the world top 10%
3.5k
per year above
Top-10% rate
10.0%
share of its works in the world top 10%
Growth, 2018-21 → 2022-25
+4%
the tick is no change
Largest producer
United States
25% of the 10 largest, 2022-now
Infectious Diseases and Tuberculosis

This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.

Which countries lead Infectious Diseases and Tuberculosis research?

By volume, the United States and India publish the most (1k and 965 works in 2022-now).

By volume, 2022-now

  1. 1 United States 1k works
  2. 2 India 965 works
  3. 3 China 730 works
  4. 4 Japan 295 works
  5. 5 United Kingdom 251 works
  6. 6 Germany 206 works
  7. 7 Brazil 197 works
  8. 8 France 183 works
  9. 9 Indonesia 155 works
  10. 10 Türkiye 152 works

How concentrated that is

The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.

United States: 25.0%India: 23.1%China: 17.5%Japan: 7.1%6 others listed: 27.4%25%largest
United States1,046 · 25.0%India965 · 23.1%China730 · 17.5%Japan295 · 7.1%6 others listed1,145 · 27.4%

Shares of the rows listed above, not of the whole node.

Which institutions lead Infectious Diseases and Tuberculosis research?

By volume in 2022-now, All India Institute of Medical Sciences publishes the most Infectious Diseases and Tuberculosis research, followed by Capital Medical University and Post Graduate Institute of Medical Education and Research.

By volume, 2022-now

  1. 1 All India Institute of Medical SciencesIndia 104 works
  2. 2 Capital Medical UniversityChina 39 works
  3. 3 Post Graduate Institute of Medical Education and ResearchIndia 36 works
  4. 4 Harvard UniversityUnited States 33 works
  5. 5 Banaras Hindu UniversityIndia 29 works
  6. 6 Mayo ClinicUnited States 26 works
  7. 7 University of DelhiIndia 25 works
  8. 8 Johns Hopkins UniversityUnited States 23 works
  9. 9 Sichuan UniversityChina 23 works
  10. 10 Zhejiang UniversityChina 21 works

Who are the leading researchers in Infectious Diseases and Tuberculosis?

The most-cited researchers publishing on Infectious Diseases and Tuberculosis include Jun Wang, Matthias Egger and Gordon Henry Guyatt.

  1. 1 Jun Wang China 340k citations
  2. 2 Matthias Egger Switzerland 326k citations
  3. 3 Gordon Henry Guyatt Canada 315k citations

Ranked by citations received across their whole record, among researchers with at least three works on this topic.

What are the most cited papers in Infectious Diseases and Tuberculosis?

The most cited paper in Infectious Diseases and Tuberculosis is "An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases" (David E. Griffith, Timothy R. Aksamit, Barbara A. Brown‐Elliott et al., 2007), with 6,190 citations. Next come "Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent" (3,730) and "The Growing Burden of Tuberculosis" (2,571).

Most cited papers
#PaperReleasedCitations
1 An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases David E. Griffith, Timothy R. Aksamit, Barbara A. Brown‐Elliott et al. · American Journal of Respiratory and Critical Care Medicine Feb 2007 6,190
2 Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent Joseph Keane, Sharon K. Gershon, Robert P. Wise et al. · New England Journal of Medicine Open access 11 Oct 2001 3,730
3 The Growing Burden of Tuberculosis Elizabeth Lucy Corbett, Catherine J. Watt, Neff Walker et al. · Archives of Internal Medicine 12 May 2003 2,571
4 An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection. JoAnne L. Flynn, John K.C. Chan, K J Triebold et al. · The Journal of Experimental Medicine Open access Dec 1993 2,497
5 Diagnosis and Management of Prosthetic Joint Infection: Clinical Practice Guidelines by the Infectious Diseases Society of Americaa Douglas R. Osmon, Elie F. Berbari, Anthony Robert Berendt et al. · Clinical Infectious Diseases Open access 6 Oct 2012 2,296
All 100 most cited papers, with filters and sorting

Where is Infectious Diseases and Tuberculosis research done?

The largest centres of Infectious Diseases and Tuberculosis research in 2022-now are New Delhi (India), Beijing (China), London (United Kingdom) and Tokyo (Japan). Among places with at least 20 works in it, it is an unusually large share of all research in Casablanca and Marrakesh.

Largest cities, 2022-now

  1. 1 New DelhiIndia 122 works
  2. 2 BeijingChina 105 works
  3. 3 LondonUnited Kingdom 88 works
  4. 4 TokyoJapan 68 works
  5. 5 ParisFrance 64 works
  6. 6 MoscowRussia 61 works
  7. 7 ChennaiIndia 54 works
  8. 8 MumbaiIndia 52 works
  9. 9 SeoulSouth Korea 51 works
  10. 10 São PauloBrazil 51 works

Where it is the local speciality

  1. CasablancaMA · 30.0 works9.7×
  2. MarrakeshMA · 23.9 works9.6×
← less than its size predicts1×more →

Location quotient: how much more of its research is in Infectious Diseases and Tuberculosis than the world average.

See Infectious Diseases and Tuberculosis on the map

Where is the best place to study Infectious Diseases and Tuberculosis?

Among universities, judged by research, London School of Hygiene & Tropical Medicine, All India Institute of Medical Sciences and University of Cape Town score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.

0%10%20%30%mean 21.49%fractional works in this field (log) →share of work in the world top 10% →University of Cape T…London School of Hyg…Capital Medical Univ…All India Institute …
above the meannear itbelow it

One dot per university in the first ten of the table below, at the default weights. The upper left is the interesting corner: small places doing unusually strong work.

Excellenceshare of its work in the world top 10%, 2022-now and all time averaged
40%
Specialisationhow much of its work is in this field, counted up to 10× the world share
10%
Sizeits output in this field, on a log scale
30%
Growthoutput growth, counted from -20% to +20%
10%
Internationalshare of its work with a co-author abroad
10%
Each slider sets a weight; the share it gets of the score is beside it.
#UniversityScoreTop 10%SpecialisationWorksGrowth
1London School of Hygiene & Tropical MedicineUnited Kingdom 60.526.7%9.5×8 -29.2%
2All India Institute of Medical SciencesIndia 60.45.6%16.6×104 +22.0%
3University of Cape TownSouth Africa 58.728.5%8.3×16 -29.0%
4Capital Medical UniversityChina 58.122.8%6.4×39 +5.5%
5Johns Hopkins UniversityUnited States 52.822.0%2.6×23 -14.8%
6Central South UniversityChina 50.527.0%1.6×18 +71.7%
7Guangxi Medical UniversityChina 47.920.3%8.4×12 +151.1%
8University of RegensburgGermany 47.724.6%6.3×9 +133.7%
9Stellenbosch UniversitySouth Africa 47.419.4%5.5×12 -15.0%
10Harvard UniversityUnited States 46.818.0%1.8×33 -23.0%

Universities only. The score blends excellence (40%), size (30%), specialisation (10%), growth (10%), international reach (10%), 2022-now; growth compares 2018-21 with 2022-25 and counts up to +20%, since a jump from a small base is mostly noise.

Every institution in Infectious Diseases and Tuberculosis, country by country

Is Infectious Diseases and Tuberculosis research growing?

Output in 2022-2025 was 4% higher than in 2018-2021, peaking in 2021. The fastest-growing topics are Infectious Diseases and Tuberculosis.

still counting19801990200020102020
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Infectious Diseases and Tuberculosis as a percentage of every work published that year, 0.027% in 2024.

still counting0.020%0.040%0.060%Infectious Diseases and Tuberculosis0.026% in 202519801990200020102020

Fractional works of Infectious Diseases and Tuberculosis over all fractional works that year. How the balance of science has shifted.

How much of it reaches the world top 10%

Year by year.

still counting5%10%15%Infectious Diseases and Tuberculosis10.2% in 2025200020102020

Of each year's works in it, the share that reached the world's 10% most cited for their field and year. A field is the world for its own topics, so there is no other line to hold it against.

Which topics inside it are moving

Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.

Discussion

Ask a question or share a note about Infectious Diseases and Tuberculosis. Posts are plain text and can be reported.